Although low expression of these core clock genes is common in malignancy, circadian rhythm abnormalities contribute to tumor proliferation and metastasis.[11, 12] Indeed, circadian rhythm disorders have been implicated as potentially carcinogenic, presenting latent risk.[13] Hence, examining circadian rhythm modulation and the synergistic relationships between clock and nonclock transcription factors may promote cancer therapy development. Here, CLOCK is linked to cancer.